CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 51 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,079,000 | +11.4% | 286,334 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $1,867,000 | +18.8% | 287,248 | -0.2% | 0.00% | 0.0% |
| Q2 2016 | $1,571,000 | +51.3% | 287,797 | +29.7% | 0.00% | +100.0% |
| Q1 2016 | $1,038,000 | -4.1% | 221,901 | +2.1% | 0.00% | 0.0% |
| Q4 2015 | $1,082,000 | +33.6% | 217,369 | +0.9% | 0.00% | 0.0% |
| Q3 2015 | $810,000 | -38.8% | 215,377 | -2.2% | 0.00% | -50.0% |
| Q2 2015 | $1,323,000 | +49.8% | 220,166 | +39.7% | 0.00% | +100.0% |
| Q1 2015 | $883,000 | +89.5% | 157,602 | +1.5% | 0.00% | 0.0% |
| Q4 2014 | $466,000 | +11.5% | 155,218 | -0.5% | 0.00% | 0.0% |
| Q3 2014 | $418,000 | -5.4% | 155,954 | -1.3% | 0.00% | 0.0% |
| Q2 2014 | $442,000 | -31.5% | 158,013 | +6.8% | 0.00% | 0.0% |
| Q1 2014 | $645,000 | +37.5% | 147,964 | +1.3% | 0.00% | 0.0% |
| Q4 2013 | $469,000 | +98.7% | 146,017 | -1.5% | 0.00% | – |
| Q3 2013 | $236,000 | +0.4% | 148,186 | +9.0% | 0.00% | – |
| Q2 2013 | $235,000 | – | 135,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |